Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Endocrine
Erschienen in: Endocrine 1/2022

28.04.2022 | Original Article

Prenatal and early life factors and type 1 diabetes

verfasst von: Alexia G. Abela, Stephen Fava

Erschienen in: Endocrine | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

The prevalence of type 1 diabetes is increasing worldwide, suggesting that unknown environmental factors are becoming increasingly important in its pathogenesis.

Aim

The aim of the study was to investigate the possible role of a number of prenatal and perinatal factors in the aetiology of type 1 diabetes.

Methods

Mothers of patients diagnosed with type 1 diabetes (cases) and mothers of children born on the same day and of the same sex as type 1 diabetes patients (controls) were interviewed on a number of prenatal and perinatal factors of interest.

Results

Hand washing prior to eating, frequency of bathing and total stress score were found to be positively associated with the development of type 1 diabetes on univariate analyses. Hand-washing prior to eating and frequency of house cleaning were independently associated with an increased risk of type 1 diabetes, whilst getting dirty was associated with a reduced risk in multivariate analyses. There was no association of type 1 diabetes to removing of outdoor shoes indoors or to the age of first attendance to school or pre-school. There were also no significant associations to parental smoking, parental age, birth order, infant feeding, antibiotic use, mode of delivery or birth weight.

Conclusion

Our data suggest that factors that affect the skin or gut microbiome might be more important than infections or factors affecting the microbiome at other sites.
Literatur
1.
P. Onkamo, S. Vaananen, M. Karvonen, J. Tuomilehto, Worldwide increase in incidence of Type I diabetes–the analysis of the data on published incidence trends. Diabetologia 42, 1395–403 (1999)PubMedCrossRef
2.
C.C. Patterson, G.G. Dahlquist, E. Gyürüs, A. Green, G. Soltész; EURODIAB Study Group, Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet 373(9680), 2027–2033 (2009)PubMedCrossRef
3.
4.
R.A. Oram, A.G. Jones, R.E. Besser, B.A. Knight, B.M. Shields, R.J. Brown, A.T. Hattersley, T.J. McDonald, The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia 57, 187–91 (2014). Erratum in: Diabetologia. 2014;57:262PubMedCrossRef
5.
G.D. Ogle, S. James, D. Dabelea, C. Pihoker, J. Svennson, J. Maniam, E.L. Klatman, C.C. Patterson, Global estimates of incidence of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Atlas, 10th Edition. Diabetes Res Clin. Pr. 7, 109083 (2021)
6.
C.C. Patterson, S. Karuranga, P. Salpea, P. Saeedi, G. Dahlquist, G. Soltesz, G.D. Ogle, Worldwide estimates of incidence, prevalence and mortality of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin. Pr. 157, 107842 (2019)CrossRef
7.
S.J. Livingstone, H.C. Looker, E.J. Hothersall, S.H. Wild, R.S. Lindsay, J. Chalmers, S. Cleland, G.P. Leese, J. McKnight, A.D. Morris, D.W. Pearson, N.R. Peden, J.R. Petrie, S. Philip, N. Sattar, F. Sullivan, H.M. Colhoun, Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med. 9(10), e1001321 (2012)PubMedPubMedCentralCrossRef
8.
A. Tran-Duy, J. Knight, P.M. Clarke, A.M. Svensson, B. Eliasson, A.J. Palmer, Development of a life expectancy table for individuals with type 1 diabetes. Diabetologia 64, 2228–2236 (2021)PubMedPubMedCentralCrossRef
9.
M. Sussman, J. Benner, M.J. Haller, M. Rewers, R. Griffiths, Estimated lifetime economic burden of type 1 diabetes. Diabetes Technol. Ther. 22(2), 121–130 (2020)PubMedCrossRef
10.
S. Fourlanos, M.D. Varney, B.D. Tait, G. Morahan, M.C. Honeyman, P.G. Colman, L.C. Harrison, The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 31, 1546–9 (2008)PubMedPubMedCentralCrossRef
11.
J. Ilonen, A. Hammais, A.P. Laine, J. Lempainen, O. Vaarala, R. Veijola, O. Simell, M. Knip, Patterns of β-cell autoantibody appearance and genetic associations during the first years of life. Diabetes 62, 3636–40 (2013)PubMedPubMedCentralCrossRef
12.
E.Z. Giannopoulou, C. Winkler, R. Chmiel, C. Matzke, M. Scholz, A. Beyerlein, P. Achenbach, E. Bonifacio, A.G. Ziegler, Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes. Diabetologia 58, 2317–23 (2015)PubMedCrossRef
13.
14.
A.G. Abela, S. Fava, Association of incidence of type 1 diabetes with mortality from infectious disease and with antibiotic susceptibility at a country level. Acta Diabetol. 50, 859–65 (2013)PubMedCrossRef
15.
A.G. Abela, S. Fava, Does the level of bacterial exposure in early life impact the risk of Type 1 diabetes? Expert Rev. Clin. Immunol. 9, 695–7 (2013)PubMedCrossRef
16.
A.G. Abela, S. Fava, Why is the incidence of type 1 diabetes increasing? Curr. Diabetes Rev. 17, e030521193110 (2021)PubMedCrossRef
17.
Y. Vandenplas, V.P. Carnielli, J. Ksiazyk, M.S. Luna, N. Migacheva, J.M. Mosselmans, J.C. Picaud, M. Possner, A. Singhal, M. Wabitsch, Factors affecting early-life intestinal microbiota development. Nutrition 78, 110812 (2020)PubMedCrossRef
18.
R.R. Goldacre, Associations between birthweight, gestational age at birth and subsequent type 1 diabetes in children under 12: a retrospective cohort study in England, 1998-2012. Diabetologia 61, 616–625 (2018)PubMedCrossRef
19.
T.H. Holmes, R.H. Rahe, The social readjustment rating scale. J. Psychosom. Res. 11, 213–8 (1967)PubMedCrossRef
20.
21.
E.A. Gale, The rise of childhood type 1 diabetes in the 20th century. Diabetes 51, 3353–61 (2002)PubMedCrossRef
22.
23.
M. Caputo, B. Zoch-Lesniak, A. Karch, M. Vital, F. Meyer, F. Klawonn, A. Baillot, D.H. Pieper, R.T. Mikolajczyk, Bacterial community structure and effects of picornavirus infection on the anterior nares microbiome in early childhood. BMC Microbiol. 19, 1 (2019)PubMedPubMedCentralCrossRef
24.
C.R. Cardwell, D.J. Carson, C.C. Patterson, No association between routinely recorded infections in early life and subsequent risk of childhood-onset Type 1 diabetes: a matched case-control study using the UK General Practice Research Database. Diabet. Med. 25, 261–7 (2008)PubMedCrossRef
25.
26.
A.J. Probst, A.K. Auerbach, C. Moissl-Eichinger, Archaea on human skin. PloS One 8, 6 (2013)
27.
S. Leininger, T. Urich, M. Schloter, L. Schwark, J. Qi, G.W. Nicol, J.I. Prosser, S.C. Schuster, C. Schleper, Archaea predominate among ammonia-oxidizing prokaryotes in soils. Nature 442(7104), 806–9 (2006)PubMedCrossRef
28.
M.M.M. Kuypers, H.K. Marchant, B. Kartal, The microbial nitrogen-cycling network. Nat. Rev. Microbiol. 16, 263–276 (2018)PubMedCrossRef
29.
S. Shiva, Nitrite: a physiological store of nitric oxide and modulator of mitochondrial function. Redox Biol. 2013(1), 40–44 (2013)CrossRef
30.
A. García-Ortiz, J.M. Serrador, Nitric oxide signaling in T cell-mediated immunity. Trends Mol. Med 24, 412–427 (2018)PubMedCrossRef
31.
Y. Jianjun, R. Zhang, G. Lu, Y. Shen, L. Peng, C. Zhu, M. Cui, W. Wang, P. Arnaboldi, M. Tang, M. Gupta, C.F. Qi, P. Jayaraman, H. Zhu, B. Jiang, S.H. Chen, J.C. He, A.T. Ting, M.M. Zhou, V.K. Kuchroo, H.C. Morse III, K. Ozato, A.G. Sikora, H. Xiong, T cell–derived inducible nitric oxide synthase switches off Th17 cell differentiation. J. Exp. Med. 210, 1447–62 (2013)CrossRef
32.
S. Romagnani, T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 85, 9–18 (2000). quiz 18, 21PubMedCrossRef
33.
P. Fasching, M. Stradner, W. Graninger, C. Dejaco, J. Fessler, Therapeutic potential of targeting the Th17/Treg axis in autoimmune disorders. Molecules 22, 134 (2017)PubMedCentralCrossRef
34.
P. Kumar, G. Subramaniyam, Molecular underpinnings of Th17 immune-regulation and their implications in autoimmune diabetes. Cytokine 71, 366–76 (2015)PubMedCrossRef
35.
B.J. Oleson, K.A. Broniowska, A. Naatz, N. Hogg, V.L. Tarakanova, J.A. Corbett, Nitric oxide suppresses β-cell apoptosis by inhibiting the DNA damage response. Mol. Cell Biol. 36(15), 2067–77 (2016)PubMedPubMedCentralCrossRef
36.
N. Fierer, M. Hamady, C.L. Lauber, R. Knight, The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proc. Natl. Acad. Sci. 105, 17994–17999 (2008)PubMedPubMedCentralCrossRef
37.
S.L. Edmonds-Wilson, N.I. Nurinova, C.A. Zapka, N. Fierer, M. Wilson, Review of human hand microbiome research. J. Dermatological Sci. 80, 3–12 (2015)CrossRef
38.
C.T. Brown, A.G. Davis-Richardson, A. Giongo, K.A. Gano, D.B. Crabb, N. Mukherjee, G. Casella, J.C. Drew, J. Ilonen, M. Knip, H. Hyöty, R. Veijola, T. Simell, O. Simell, J. Neu, C.H. Wasserfall, D. Schatz, M.A. Atkinson, E.W. Triplett, Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One 6(10), e25792 (2011)PubMedPubMedCentralCrossRef
39.
G.A. Rook, Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health. Proc. Natl. Acad. Sci. 110, 18360–18367 (2013)PubMedPubMedCentralCrossRef
40.
P. Hemarajata, J. Versalovic, Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therapeutic Adv. Gastroenterol. 6, 39–51 (2013)CrossRef
41.
R.R. Dunn, N. Fierer, J.B. Henley, J.W. Leff, H.L. Menninger, Home life: factors structuring the bacterial diversity found within and between homes. PLoS One 8, e64133 (2013)PubMedPubMedCentralCrossRef
42.
A.M. Womack, B.J. Bohannan, J.L. Green, Biodiversity and biogeography of the atmosphere. Philos. Trans. R. Soc. B Biol. Sci. 365(1558), 3645–3653 (2010)CrossRef
43.
44.
45.
A. Tsatsoulis, The role of stress in the clinical expression of thyroid autoimmunity. Ann. NY Acad. Sci. 1088, 382–95 (2006)PubMedCrossRef
46.
G.E. Miller, M.L. Murphy, R. Cashman, R. Ma, J. Ma, J.M. Arevalo, M.S. Kobor, S.W. Cole, Greater inflammatory activity and blunted glucocorticoid signaling in monocytes of chronically stressed caregivers. Brain Behav. Immun. 41, 191–9 (2014)PubMedPubMedCentralCrossRef
47.
E.K. Grishman, P.C. White, R.C. Savani, Toll-like receptors, the NLRP3 inflammasome, and interleukin-1β in the development and progression of type 1 diabetes. Pediatr. Res. 71(6), 626–632 (2012)PubMedCrossRef
48.
Y.L. Chen, Y.C. Qiao, Y.H. Pan, Y. Xu, Y.C. Huang, Y.H. Wang, L.J. Geng, H.L. Zhao, X.X. Zhang, Correlation between serum interleukin-6 level and type 1 diabetes mellitus: a systematic review and meta-analysis. Cytokine 94, 14–20 (2017)PubMedCrossRef
49.
S.U. Thorsen, C.B. Pipper, S. Eising, K. Skogstrand, D.M. Hougaard, J. Svensson, F. Pociot, Neonatal levels of adiponectin, interleukin-10 and interleukin-12 are associated with the risk of developing type 1 diabetes in childhood and adolescence: a nationwide Danish case-control study. Clin. Immunol. 174, 18–23 (2017)PubMedCrossRef
50.
M.H. Blotta, R.H. DeKruyff, D.T. Umetsu, Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes. J. Immunol. 158, 5589–5595 (1997)PubMed
51.
M. Rachmiel, O. Bloch, A.A. Shaul, G. Ben-Yehudah, Z. Bistritzer, N. Weintrob, R. Ofan, M.J. Rapoport, Young patients with both type 1 diabetes mellitus and asthma have a unique IL-12 and IL-18 secretory pattern. Pediatr. Diabetes 12, 596–603 (2011)PubMedCrossRef
52.
L.F. Lee, B. Xu, S.A. Michie, G.F. Beilhack, T. Warganich, S. Turley, H.O. McDevitt, The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation. Proc. Natl. Acad. Sci. USA 102(44), 15995–6000 (2005)PubMedPubMedCentralCrossRef
53.
Metadaten
Titel
Prenatal and early life factors and type 1 diabetes
verfasst von
Alexia G. Abela
Stephen Fava
Publikationsdatum
28.04.2022
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2022
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03057-0

Weitere Artikel der Ausgabe 1/2022

Endocrine 1/2022 Zur Ausgabe

Original Article

Neuroendocrine neoplasms of the ovary: an analysis of clinicopathological characteristics and prognosis with a focus on histological grading

Original Article

Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours

Original Article

Differentiated thyroid carcinoma in the elderly: influence of age on disease-free and overall survival

Correction

Correction: Prospective study on the clinical relevance of 18F-DOPA positron emission tomography/computed tomography in patients with medullary thyroid carcinoma

Research Letter

Papillary thyroid carcinoma as first and isolated neoplastic disease in a Lynch syndrome family member with a germline MLH1 mutation

Original Article

Risk-stratified papillary thyroid microcarcinoma: post-operative management and treatment outcome in a single center

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise